Product Categories
| Country: | United States |
|---|---|
| Tel: | 552-7181 |
| E-mail: | sales@aladdinsci.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 14078 Meridian Parkway, Riverside |
|
Aladdin Scientific Corporation is a listed company on the A-share Science and Technology Board (stock code: 688179), which has been deeply engaging in the field of scientific research reagents for more than ten years, and is a manufacturer of scientific research reagents integrating research and development, production and sales. After years of exploration, accumulation and development, it owns six major product lines of chemistry and biochemistry reagents, material sciences, drug-targeting ligands, proteins, antibodies, and I-Quip?? labware. Product line.
Relying on its own e-commerce platform (www.aladdinsci.com), Aladdin provides a huge product line covering hundreds of thousands of scientific research reagents and thousands of consumables/instruments, which are widely used in colleges and universities, scientific research institutes, medical treatment, medicine, pharmaceuticals, diagnostics, new materials, new energy, energy conservation and environmental protection, aerospace and other high-tech industries as well as their upstream and downstream enterprises. Corporation
|
|
| Product Name | MF | CAS | Details |
|---|
| Denthyrsinin | C17H16O5 | 118169-17-8 | Details |
| Dryocrassin ABBA | C43H48O16 | 12777-70-7 | Details |
| 2,3-dimethylcyclohexa-2,5-diene-1,4-dione | C8H8O2 | 526-86-3 | Details |
| 2,5-Dimethyl-2-hexanol | C8H18O | 3730-60-7 | Details |
| β-D-Glucopyranoside,(3β,6α,16β,20R,24S)-3-[(3,4-di-O-acetyl-β-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl | C45H72O16 | 1324005-51-7 | Details |
| DL-Tryptophan octyl ester hydrochloride | C19H29ClN2O2 | 6278-90-6 | Details |
| 4,6-Dibromoquinoline | C9H5Br2N | 927801-13-6 | Details |
| 1-Dodecylboronic acid pinacol ester | C18H37BO2 | 177035-82-4 | Details |
| 4,7-Dimethyl-5-decyn-4,7-diol | C12H22O2 | 126-87-4 | Details |
| Fidarestat | C12H10FN3O4 | 136087-85-9 | Details |
| Diosgenin-3-O-β-D-xylosyl-(1→3)-β-glucoside | C38H60O12 | 65604-99-1 | Details |
| 4-(Difluoromethyl)-1-fluoro-2-nitrobenzene | C7H4F3NO2 | 61324-89-8 | Details |
| 3,5-Diethynylbenzoic acid | C11H6O2 | 883106-26-1 | Details |
| Fluorogestone acetate | C23H31FO5 | 2529-45-5 | Details |
| Delta3,2-Hydroxylbakuchiol | C18H24O2 | 178765-49-6 | Details |
| Disodium 5-bromo-4-chloro-1H-indol-3-yl phosphate | C8H4BrClNO4PNaH2O | 304656-10-8 | Details |
| DusQ1 phosphoramidite | C55H63N8O8P | 374591-94-3 | Details |
| 4,4’-Difluoro-2,2’-bipyridine | C10H6F2N2 | 1189458-67-0 | Details |
| DusQ2 phosphoramidite | C54H61N8O9P | 374591-98-7 | Details |
| 5,6-Dimethyl-2-benzimidazolinone | C9H10N2O | 2033-30-9 | Details |
| Dihydrochelerythrine | C21H19NO4 | 6880-91-7 | Details |
| 2,3-Dihydroxypropyl benzoate | C10H12O4 | 3376-59-8 | Details |
| 1,6-Dimethyl-2,3-dihydroquinolin-4(1H)-one | C11H13NO | 959699-02-6 | Details |
| 2,6-Dibromo-4-n-propylaniline | C9H11Br2N | 10546-64-2 | Details |
| Diosgenin-3-O-rhamnosyl(1-2)[glucosyl(1-6)]glucoside | C45H72O17 | 1072072-37-7 | Details |
| Fosgonimeton | C27H45N4O8P | 2093305-05-4 | Details |
| 3,4-Dihydro-2H-1-benzopyran | C9H10O | 493-08-3 | Details |
| Dracaenoside F | C39H62O13 | 109460-83-5 | Details |
| 5,6-Dimethylbenzo[d]thiazole-2-thiol | C9H9NS2 | 80087-70-3 | Details |
| dendronobilin B | C15H24O5 | 1002717-96-5 | Details |
| Forsythoside I | C29H36O15 | 1177581-50-8 | Details |
| GW 766994 | C21H24Cl2N4O3 | 408303-43-5 | Details |
| Gly-Gly-Gly-PEG3-TCO | C23H41N5O8 | 2353409-81-9 | Details |
| GSK9311 | C24H31N5O3 | 1923851-49-3 | Details |
| G5-7 | C22H19F2NO3 | 939681-36-4 | Details |
| Fanotaprim | C19H22N8O | 2120282-75-7 | Details |
| FAM-xtra Phosphoramidite | C46H56F2N3O10P | 2304636-67-5 | Details |
| 4-Dimethylaminobenzhydrazide | C9H13N3O | 19353-92-5 | Details |
| Delavinone;Sinpeimine | C27H43NO2 | 96997-98-7 | Details |
| GLPG0492 | C19H14F3N3O3 | 1215085-92-9 | Details |
| Glycine, N-[(1,1-dimethylethoxy)carbonyl]glycyl-, 2,5-dioxo-1-pyrrolidinyl ester | C13H19N3O7 | 29248-48-4 | Details |
| 2,6-Dichloro-trans-cinnamic acid | C9H6Cl2O2 | 20595-49-7 | Details |
| Dehydropachymic acid | C33H50O5 | 77012-31-8 | Details |
| GSK1059865 | C20H23BrFN3O2 | 1191044-58-2 | Details |
| GSK864 | C30H31FN6O4 | 1816331-66-4 | Details |
| 1-(2,4-Dichlorophenyl)cyclopropanecarboxylic acid | C10H8Cl2O2 | 84604-70-6 | Details |
| 5-fluoro-N-methylpyridin-2-amine | C6H7FN2 | 868636-72-0 | Details |
| Gly-PEG3-amine, TFA salt | C12H27N3O4 | 2110448-97-8 | Details |
| GPR81 agonist 1 | C22H30N4O2S2 | 1620992-67-7 | Details |
| Fast Corinth V | C15H14Cl4N5O3Zn- | 61966-14-1 | Details |
| 2-(Dimethylamino)-2-phenylacetic acid | C10H13NO2 | 14758-99-7 | Details |
| GSK2647544 | C24H18ClF3N4O3 | 1380426-95-8 | Details |
| Genevant CL1 | C39H73NO2 | 1450888-71-7 | Details |
| GW-6604 | C19H14N4 | 452342-37-9 | Details |
| FABP-IN-1 | C30H26O6 | 2132990-90-8 | Details |
| Firibastat | C8H20N2O6S4 | 648927-86-0 | Details |
| 3,3'-Dihydroxy-[1,1'-biphenyl]-4,4'-dicarboxylic acid | C14H10O6 | 861533-46-2 | Details |
| GSK256073 | C10H13ClN4O2 | 862892-90-8 | Details |
| GSTO-IN-2 | C33H52N2O9 | 1202710-57-3 | Details |
| 8-formyl ophiopogonone B | C19H16O6 | 1316224-74-4 | Details |
| Gimatecan | C25H25N3O5 | 292618-32-7 | Details |
| GDC-0339 | C20H22F3N7OS | 1428569-85-0 | Details |
| GPR120 modulator 1 | C19H16ClNO4S | 1050506-75-6 | Details |
| GSK321 | C28H28FN5O3 | 1816331-63-1 | Details |
| 2-Fluoro-4-(pentafluorothio)benzoic acid | C7H4F6O2S | 1240257-03-7 | Details |
| 4-Feruloylquinic acid | C17H20O9 | 2613-86-7 | Details |
| 2-(4-Fluorophenyl)-1H-imidazole | C9H7FN2 | 4278-08-4 | Details |
| GSK205 | C24H25BrN4S | 1263068-83-2 | Details |
| FGFR1/DDR2 inhibitor 1 | C28H22F3N5O | 2308497-58-5 | Details |
| FASN-IN-3 | C24H24N4O | 2097262-60-5 | Details |
| 2-Fluoropyrimidine | C4H3FN2 | 31575-35-6 | Details |
| 4-Fluorocinnamic Acid | C9H7FO2 | 14290-86-9 | Details |
| 2-Fluoro-5-(trifluoromethyl)benzophenone | C14H8F4O | 199292-40-5 | Details |
| Gefitinib-d8 | C22H24ClFN4O3 | 857091-32-8 | Details |
| 8-formyl ophiopogonanone B | C19H18O6 | 1316224-76-6 | Details |
| 3-Fluoro-5-(trifluoromethyl)picolinic acid | C7H3F4NO2 | 89402-28-8 | Details |
| Glucagon receptor antagonists-2 | C22H30FNO2 | 202917-18-8 | Details |
| Gymnemic acid I | C43H66O14 | 122168-40-5 | Details |
| Gilteritinib hemifumarate | C33H48N8O7 | 1254053-84-3 | Details |
| GPR120 Agonist 2 | C22H25ClO4 | 1234844-11-1 | Details |
| 3-Fucosyllactose | C18H32O15 | 41312-47-4 | Details |
| GW274150 phosphate | C8H20N3O6PS | 438542-15-5 | Details |
| Gly-Gly-Gly-PEG4-DBCO | C35H46N6O9 | 2353409-80-8 | Details |
| Ganoderic acid TR | C30H44O4 | 862893-75-2 | Details |
| GSK2798745 | C25H28N6O3 | 1419609-94-1 | Details |
| (S)-GNE-140 | C25H23ClN2O3S2 | 2003234-64-6 | Details |
| Fluorescein II CEP | C67H76N3O14P | 1027512-13-5 | Details |
| GW280264X | C28H41N5O6S | 866924-39-2 | Details |
| GNE-9815 | C26H22FN5O2 | 2729996-45-4 | Details |
| Germacrene D | C15H24 | 23986-74-5 | Details |
| GPX4-IN-3 | C29H24ClN3O3S | 2761004-85-5 | Details |
| GSK1940029 | C18H16Cl2N4O2 | 1150701-66-8 | Details |
| GAT211 | C22H18N2O2 | 102704-40-5 | Details |
| GSK-3484862 | C19H19N5OS | 2170136-65-7 | Details |
| Gly-Gly-Gly-PEG4-methyltetrazine | C23H34N8O7 | 2353409-82-0 | Details |
| GPR84 antagonist 2 | C28H18Cl2NaO4PS2 | 2244269-74-5 | Details |
| Ginsenoside F4 | C42H70O12 | 181225-33-2 | Details |
| Forsythoside E | C20H30O12 | 93675-88-8 | Details |
| Glesatinib hydrochloride | C31H28ClF2N5O3S2 | 1123838-51-6 | Details |
| GOAT-IN-1 | C18H13ClF3NO3S | 1452473-54-9 | Details |
| Product Total： Product Page： | ||||
| 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 | ||||